Literature DB >> 30580124

heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/β.

Lin-Lin Ma1, Peng Zhang2, Hui-Qiang Wang2, Yan-Fei Li3, Jin Hu2, Jian-Dong Jiang4, Yu-Huan Li5.   

Abstract

The innate immunity plays an essential role in defending infection of Influenza A virus (IAV). The regulatory effect of heme oxygenase-1 (HO-1), a cytoprotective enzyme, on innate immunity has been revealed. In this study, we aim to confirm the antiviral effect of CoPP (Cobaltic Protoporphyrin IX Chloride), a potent HO-1 inducer on IAV infection and elucidate the possible mechanism of HO-1-mediated host innate immune responses. Our results show that CoPP exhibits broad-spectrum antiviral activities against IAV. Furthermore, CoPP attenuates IAV replication through inducing type I IFNs response, not depending on HO-1 enzymatic activity. We also provide direct evidence that HO-1-mediated type I IFN response activation is largely due to its interaction with IRF3, which then promotes IRF3 phosphorylation and nuclear translocation. These results suggest that HO-1 agonist CoPP suppresses IAV replication through IRF3-mediated generation of IFN-α/β. Thus, therapeutic induction of HO-1 might be a promising strategy to combat IAV epidemics.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  CoPP; Heme oxygenase-1; IFN-α/β; IRF3; Influenza virus

Mesh:

Substances:

Year:  2018        PMID: 30580124     DOI: 10.1016/j.virol.2018.11.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Induction of HOXA3 by Porcine Reproductive and Respiratory Syndrome Virus Inhibits Type I Interferon Response through Negative Regulation of HO-1 Transcription.

Authors:  Yingtong Feng; Xuyang Guo; Hong Tian; Yuan He; Yang Li; Xuelian Jiang; Haixue Zheng; Shuqi Xiao
Journal:  J Virol       Date:  2021-12-01       Impact factor: 6.549

2.  The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells.

Authors:  Theodoros Kelesidis; Sharma Madhav; Anton Petcherski; Hugo Cristelle; Ellen O'Connor; Nan W Hultgren; Eleni Ritou; David S Williams; Orian S Shirihai; Srinivasa T Reddy
Journal:  Virulence       Date:  2021-12       Impact factor: 5.428

3.  DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response.

Authors:  Ming Zhong; Huiqiang Wang; Linlin Ma; Haiyan Yan; Shuo Wu; Zhengyi Gu; Yuhuan Li
Journal:  Virol J       Date:  2019-02-20       Impact factor: 4.099

4.  Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.

Authors:  Maxime Rossi; Michael Piagnerelli; Alain Van Meerhaeghe; Karim Zouaoui Boudjeltia
Journal:  Med Hypotheses       Date:  2020-09-03       Impact factor: 1.538

5.  Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.

Authors:  Sheila Maestro; Karol M Córdoba; Cristina Olague; Josepmaria Argemi; Matías A Ávila; Gloria González-Aseguinolaza; Cristian Smerdou; Antonio Fontanellas
Journal:  Biomed Pharmacother       Date:  2021-02-13       Impact factor: 6.529

6.  Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2.

Authors:  Mya Myat Ngwe Tun; Takaya Sakura; Yasuteru Sakurai; Yohei Kurosaki; Daniel Ken Inaoka; Norifumi Shioda; Jiro Yasuda; Kiyoshi Kita; Kouichi Morita
Journal:  Trop Med Health       Date:  2022-01-07

Review 7.  A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?

Authors:  Ayelen Toro; María Sol Ruiz; Sofia Lage-Vickers; Pablo Sanchis; Agustina Sabater; Gaston Pascual; Rocio Seniuk; Florencia Cascardo; Sabrina Ledesma-Bazan; Felipe Vilicich; Elba Vazquez; Geraldine Gueron
Journal:  Antioxidants (Basel)       Date:  2022-01-29

8.  Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Prog Cardiovasc Dis       Date:  2020-02-12       Impact factor: 8.194

9.  SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.

Authors:  Juan Bizzotto; Pablo Sanchis; Mercedes Abbate; Sofía Lage-Vickers; Rosario Lavignolle; Ayelén Toro; Santiago Olszevicki; Agustina Sabater; Florencia Cascardo; Elba Vazquez; Javier Cotignola; Geraldine Gueron
Journal:  iScience       Date:  2020-09-23

10.  Upregulation of nuclear factor E2-related factor 2 (Nrf2) represses the replication of herpes simplex virus type 1.

Authors:  Li Zhang; Jiao Wang; Zhan Wang; Ying Li; Hui Wang; Hongtu Liu
Journal:  Virol J       Date:  2022-01-31       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.